Skip to content
OR

Oriental Remedies & Herbals

526989 BSE
Price unavailable

In the Sep 2025 quarter, revenue was ₹138 Cr, against ₹84 Cr a year earlier and net profit was ₹24 Cr, against ₹5 Cr a year earlier (compared with Sep 2024). Promoters held 32.47% of Oriental Remedies & Herbals in Dec 2025, unchanged from Sep 2025.

No price data available

Peer Comparison

Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹1,765.1035.014,23,507 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
₹9,651.0087.592,56,204 Cr15.290.32%15.32%18.96%11,682 Cr2,925 Cr
₹4,595.6072.141,74,802 Cr9.510.82%12.16%9.06%17,058 Cr2,156 Cr
₹2,190.00108.201,18,328 Cr22.330.09%16.38%19.67%7,323 Cr1,090 Cr
₹1,181.4026.291,17,845 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
₹1,337.7034.651,11,655 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
₹1,362.0032.631,10,030 Cr3.110.96%11.21%14.88%28,589 Cr3,356 Cr
———————332 Cr52 Cr
Median 8 companies₹1,765.1035.011,18,328 Cr5.070.61%13.79%17.94%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

1
  • Company has low interest coverage ratio.

Growth Rate

Net Income Growth
0%

change over 1 year

Quarterly Results

Particulars Sep 2024Mar 2025Sep 2025
Sales
84
110
138
Expenses
76
78
106
Operating Profit
8
32
31
OPM %
10%
29%
23%
Other Income
0
1
2
Interest
1
1
1
Depreciation
0
0
0
PBT
8
31
31
Tax %
31%
26%
24%
Net Profit
5
23
24
EPS (₹)
—
18.2
13.78
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2011Mar 2012
Sales
0
0
Expenses
0.01
0.01
Operating Profit
-0.01
-0.01
Other Income
0
0
Interest
0
0
Depreciation
0
0
PBT
-0.01
-0.01
Tax %
0%
0%
Net Profit
-0.01
-0.01
Div. Payout %
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2011Mar 2012
Equity Capital
3.12
3.12
Reserves
-1.78
-1.79
Borrowings
0
0
Other Liabilities
0.03
0.04
Total Liabilities
1.37
1.37
Fixed Assets
0
0
CWIP
0
0
Investments
0.25
0.25
Other Assets
1.12
1.12
Total Assets
1.37
1.37
Figures in ₹ Crores

Cash Flow

Particulars Mar 2011Mar 2012
Operating
-0.01
-0.01
Investing
0
0
Financing
0
0
Net Cash Flow
-0.01
-0.01
Free Cash Flow
-0.01
-0.01
CFO/OP
100
100
Figures in ₹ Crores

Ratios

Particulars Mar 2011Mar 2012
ROCE %
—
-0.75%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Oriental Remedies & Herbals insights

27 extracted metrics + investor summaries across FY11–FY26.

Shareholding Pattern

DIIs1.21%Public64.16%FIIs2.15%Promot.32.47%As ofDec 2025

Documents

Frequently Asked Questions about Oriental Remedies & Herbals

Where is Oriental Remedies & Herbals Ltd (526989) listed?
Oriental Remedies & Herbals Ltd trades under code 526989 on the BSE.
Which sector does Oriental Remedies & Herbals Ltd belong to?
Oriental Remedies & Herbals Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Website orhl.in
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526989.md for Oriental Remedies & Herbals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More